Bin Kong
Impact in
-
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
- Cardiac Fibrosis and Remodeling
- Cardiac Arrhythmias and Treatments
Papers in
-
- Cardiovascular Function and Risk Factors 12
- Cardiac electrophysiology and arrhythmias 12
- Atrial Fibrillation Management and Outcomes 10
- Cardiac Fibrosis and Remodeling 9
- Heart Failure Treatment and Management 7
- Cardiac Arrhythmias and Treatments 7
Bin Kong
60 papers receiving 956 citations
Peers
Comparison fields: 5 of 98
- Cardiology and Cardiovascular Medicine 342
- Immunology 128
- Molecular Biology 368
- Cancer Research 78
- Oncology 136
Countries citing papers authored by Bin Kong
This map shows the geographic impact of Bin Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Kong more than expected).
Fields of papers citing papers by Bin Kong
This network shows the impact of papers produced by Bin Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Kong. The network helps show where Bin Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bin Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 38 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 14 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 25 | |
| 15 | 2018 | 44 | |
| 16 | 2017 | 27 | |
| 17 | 2017 | 23 | |
| 18 | CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. | 2014 | 16 |
| 19 | 2013 | 45 | |
| 20 | 2012 | 1 |
About Bin Kong
Bin Kong is a scholar working on Cardiology and Cardiovascular Medicine, Immunology, Oncology, Neurology and Internal Medicine, having authored 62 papers that have together received 968 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (12 papers), Cardiac electrophysiology and arrhythmias (12 papers), Atrial Fibrillation Management and Outcomes (10 papers), Cardiac Fibrosis and Remodeling (9 papers), Heart Failure Treatment and Management (7 papers), Cardiac Arrhythmias and Treatments (7 papers), Cancer-related gene regulation (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (342 citations), Immunology (128 citations), Molecular Biology (368 citations), Cancer Research (78 citations) and Oncology (136 citations). Bin Kong has collaborated with scholars based in China, United States and Australia. Frequent co-authors include He Huang, Wei Shuai, Xiaobo Jiang, Hui Fu, Hongjie Yang, Caijie Shen, Dajun Quan, Zhi‐Dong Lv, Hui Fu and Jingjing Zhang. Their work appears in journals such as International Immunopharmacology, European Journal of Pharmacology, EP Europace, Scientific Reports and ESC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.